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Abstract
Background/Aims: Regulatory T cells (Tregs) and natural killer T (NKT) cells are two distinct lymphocyte subsets that
independently regulate hepatic adaptive and innate immunity, respectively. In the current study, we examine the
interaction between Tregs and NKT cells to understand the mechanisms of cross immune regulation by these cells.
Methods: The frequency and function of Tregs were evaluated in wild type and NKT cell deficient (CD1dko) mice. In vitro
lymphocyte proliferation and apoptosis assays were performed with NKT cells co-cultured with Tregs. The ability of Tregs to
inhibit NKT cells in vivo was examined by adoptive transfer of Tregs in a model of NKT cell mediated hepatitis.
Results: CD1dko mice have a significant reduction in hepatic Tregs. Although, the Tregs from CD1dko mice remain
functional and can suppress conventional T cells, their ability to suppress activation induced NKT cell proliferation and to
promote NKT cell apoptosis is greatly diminished. These effects are CD1d dependent and require cell to cell contact.
Adoptive transfer of Tregs inhibits NKT cell-mediated liver injury.
Conclusions: NKT cells promote Tregs, and Tregs inhibit NKT cells in a CD1d dependent manner requiring cell to cell
contact. These cross-talk immune regulations provide a linkage between innate and adaptive immunity.
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Introduction
The liver is constantly exposed to food antigens, endotoxins,
and pathogens that are brought from the intestines via the portal
blood supply. As a result, the liver must generate vigorous immune
responses. This is accomplished by a large number of hepatic
Kupffer cells, natural killer (NK) cells and natural killer T (NKT)
cells, which are components of innate immunity. Meanwhile, the
liver maintains immune tolerance to avoid inappropriate immune
activation, e.g. orthotopic liver transplantation results in the long-
term allograft survival without immunosuppression [1]. One
important component of hepatic immune tolerance is represented
by lymphocytes with regulatory functions, including regulatory T
cells (Tregs) and NKT cells [2,3].
Tregs are a group of heterogenous T cells that belong to the
adaptive immune system and are actively engaged in the negative
control of a variety of immune responses, including transplant
tolerance [4], viral hepatitis [5], autoimmune hepatitis [6], and
hepatocellular carcinoma [7]. Tregs are usually CD4
+CD25
+ and
express forkhead box protein 3 (Foxp3), a specific marker and the
master transcriptional regulator of Treg development and function
[8]. In the liver, the over-regulation/suppression of Tregs has been
shown to contribute to chronic HBV/HCV infections [5,9] and
hepatocellular carcinoma [7]. In contrast, inadequate Treg
regulation contributes to autoimmune hepatitis [6], primary
biliary cirrhosis [10], and acute rejection of transplant grafts [11].
NKT cells are components of the innate immune system. They
recognize glycolipid antigens bound to the MHC class I-like
molecule, CD1d, noncovalently associated with b2 micro globulin
on various antigen presenting cells [12]. NKT cells respond to
antigen presentation by secreting large amounts of cytokines, which
in turn stimulate the proliferation and differentiation of a variety of
other immune cells that participate in the innate or adaptive
response [13]. In the liver, more than 95% of the NKT cells are
invariant NKT cells that predominantly express a conserved ab T
cell receptor [14,15]. These cells originate in the thymus, but
predominately accumulate in the liver, where they are thought to be
responsible for the regulatory function by secretion of both pro-
inflammatory and anti-inflammatory cytokines [16,17,18].
Previously, it has been shown that there is evidence of cross-talk
between Tregs and NKT cells [19]. NKT cells secrete IL-2 and
IL-4 that induce Tregs proliferation [20,21]. In addition, NKT
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Conversely, Tregs can also inhibit NKT cell proliferation and
cytokine production in vitro [23]. However, there is little evidence
of their interaction in the liver. There is also little knowledge of the
mechanism by which Tregs exert their regulatory role on NKT
cells. Thus, in the current study, we have examined the role of
Tregs in hepatic NKT cell regulation, including the mechanism of
regulation and in vivo implications of such regulation.
Methods
Ethics statement
All animal experiments fulfilled NIH and JHU criteria for the
humane treatment of laboratory animals and were approved by
the Johns Hopkins Animal Care and Use Committee
(MO07M195).
Animal experiments
Adult (age 6–8 week) male wild type (wt) C57BL6 mice were
purchased from Jackson Laboratories (Bar Harbor, ME). CD1d
knock out (CD1dko) mice were originated in Dr. Albert Bendelac’s
lab and back crossed to C57BL/6 background more than 10
generation. All mice were maintained in a temperature- and light-
controlled facility, and permitted ad libitum consumption of water
and pellet chow. To evaluate the role of IL-2 on Treg regulation,
some wt and CD1dko also received recombinant mouse IL-2
(2610
5 IU, i.p., BD Pharmingen) on days 1, 3, 5, 7, as previous
described [24], and were evaluated on day 8 for their hepatic and
splenic Treg contents. To activate NKT cell in vivo, wt mice were
injected either vehicle or 2 mgo fa-galactosylceramide (a-Galcer,
ALEXIS Biochemical, San Diego, CA) via tail vein 3 days before
harvesting the liver and collecting the blood.
Isolation and labeling of hepatic mononuclear cells
(HMNCs) and splenocytes
Mouse livers were perfused briefly with sterile saline solution to
remove blood cells, then carefully removed and minced. The liver
and spleen was homogenized and passed through a 70-micron
nylon mesh to remove connective tissue. HMNCs were then
isolated with Percoll gradient as previously described [25].
Splenocytes were isolated after removal of red blood cells. Cells
were then labeled with a CD1d tetramer (NIH tetramer facility)
loaded with a ligand (PBS-57, an analogue of a-GalCer) or anti-
mouse fluorescent antibodies against CD3, CD25, CD4, CD62L,
CD103 (Pharmingen, San Diego, CA). For apoptosis assays, cells
were stained with Annexin V and the vital dye 7-aminoactino-
mycin D (7-AAD). For intracellular staining, cells were labeled
with surface antibody, as described above, permeabilized and then
stained with antibodies against Foxp3 (eBioscience, San Diego,
CA), IL-2 or CTLA-4 (Pharmingen) according to the manufac-
turer’s instructions. After labeling, cells were evaluated by flow
cytometry (Becton Dickinson, Palo Alto, CA), and the data were
analyzed using Cell Quest software (Becton Dickinson). For
intracellular IL-2 staining only, cells were also pre-incubated with
a leukocyte activation cocktail first, which includes phorbol 1,2-
myristate 1,3-acetate (PMA, 50 ng/ml), ionomycin (500 ng/ml),
and GolgiPlug (1 ml/ml) for 5 hrs.
Cell purification and adoptive transfer
NKT cells were isolated from livers of wt mice. After isolation,
HMNCs were labeled with surface marker antibodies (anti-TCRb
and anti-NK1.1). NKT cells (NK1.1
+, TCRb
+) were isolated
through FACSVantage SE high speed sorter (Becton Dickenson).
The majority of those NKT cells (NK1.1
+, TCRb
+) were CD1d
tetramer positive, as shown in our previous study [17]. After
isolation, NKT cells were cultured with RPMI media supple-
mented with 2 mM L-glutamine. 100 U/ml penicillin, 100 mg/ml
streptomycin and 10% FCS. CD4
+CD25
+ Tregs and CD4
+CD25
-
effector T cells (Teffs) were isolated from the spleen of wt or
CD1dko mice by using a MACS regulatory T cell isolation kit
(Miltenyi Biotec, Auburn, CA). The purity of the cell separation
was ,95%, as assessed by flow cytometry.
After isolation, 1.5610
6 Tregs or Teffs were adoptively
transferred to each recipient wt mouse via tail vein injection.
24 hour after adoptive transfer, the recipient mice were injected
with 2 mgo fa-Galcer or vehicle as described above to activate
NKT cells. Liver tissue and blood were collected 3 days later.
In vitro Treg suppression assays
Two types of Treg suppression assay were performed. In one
assay, purified wt and CD1dko Tregs were co-cultured with Teffs
(5610
4/well) that were stimulated with anti-CD3 (1 mg/ml) in the
presence of APCs (mitomycin C (50 mg/ml) treated splenocytes,
5610
4/well). In the other assay, purified wt and CD1dko Tregs
were co-cultured with purified NKT cells (5610
4/well) that were
stimulated with mitomycin C treated splenocytes (5610
4/well)
loaded with a-GalCer (100 ng/ml for 3 hrs. In both assays, APCs
(either treated with mitomycin-C alone for Teffs, or treated with a-
GalCer and mitomycin-C for NKT cells) were washed extensively
before co-cultured with either NKT cells or Teffs in the presence
of untreated Tregs in round-bottom 96-well plates with RPMI
medium. Cells were co-cultured for 3 days, at the last 18 h, 0.5 Ci
[
3H] thymidine was added to the culture. Cell proliferation was
determined by incorporation of [
3H] thymidine. Culture media
were collected for cytokine determination. In separate studies,
Tregs (2610
5/well) with APCs (2610
5/well) were placed in
transwell (Millipore, Billerica, MA) chambers and cultured with
NKT (2610
5/well) cells in the present of APCs (2610
5/well) as
described above.
Tregs and NKT cells conjugation assay
Va14
+ mouse CD1d-specific NKT hybridoma (DN32.D3) were
labeled with CD1d tetramer, then incubated with freshly isolated
Tregs (1:1) from WT mice or CD1d ko mice that were labeled
with anti-CD25 mAb. After washing and fixation, cells were
analyzed by FACS. CD1d-tetramer
+CD25
+ cells indicated the
conjugation between NKT and Tregs. For CD1d blocking assays,
anti-CD1d mAb (10 mg/ml) were added to culture. In separate
Figure 1. Reduction of hepatic Tregs in CD1d deficient mice. Hepatic mononuclear cells (HMNC) and splenic cells were isolated from wt and
CD1dko C57BL6 mice. Tregs were identified by CD4, CD25, and Foxp3 staining. (n=7 each group). A) Representative dot plots of Tregs (CD25
+
Foxp3
+ cells, gated CD4
+ cells) from liver (upper panels) and spleen (lower panels). B) Mean (6SD) percentage of splenic and hepatic Tregs among
CD4 cells from wt and CD1dko mice. C) Representative histogram of intracellular IL-2 staining of HMNC from wt (open bar) and CD1dko (solid bar)
mice. D) Mean (6SD) value of intracellular IL-2 expression of total mononuclear cells (TMNC) in the liver and the spleen of wt and CD1dko mice. E)
Mean (6SD) level of IL-2 released from HMNC and splenic cells of wt and CD1dko mice measured by ELISA. F) Mean (6SD) percentage of IL-2 mRNA
expression in the liver and the spleen of wt and CD1dko mice determined by quantitative PCR. G) Mean (6SD) percentage of splenic and hepatic
Tregs in wt and CD1dko mice after they received recombinant IL-2. *p,0.05 vs wt mice.
doi:10.1371/journal.pone.0027038.g001
Hepatic Regulatory T Cells and NKT Cells
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20 mM CellTracker green dye and 5 mM CellTracker red dye,
respectively (Invitrogen, Eugene, OR), and were co-cultured for
24 hours in an incubator chamber connected to a confocal
microscope. The images were recorded every 30 min and
analyzed using velocity super-64 software (Improvision, PerkinEl-
mer). Pearson’s correlation coefficients described as the correlation
of intensity distribution between red and green channels were used
to assess NKT cell and Treg conjugation [26].
RNA Isolation and Evaluation of Hepatic Gene Expression
RNA was isolated as described previously [27,28]. cDNA was
synthesized from 5 mg of total RNA using oligo(dT) as a template
and the SuperScriptII kit (Invitrogen). Quantified PCR amplifi-
cations were performed using TagMan Gene Expression Assays
PCR Master Mix and primer sets (Applied Biosystems, Foster
City, CA). Negative controls were performed without cDNA in the
reaction mixture. The results were normalized against glyceralde-
hyde-3-phosphate dehydrogenase gene expression.
Liver Histology, serum alanine aminotransferase (ALT)
and ELISA
Thin slices of liver tissue were stained with hematoxylin. Serum
ALT was determined by the spectrophotometric method as
previously described [29]. IL-4, IFN-c and IL-2 levels in culture
media were measured with standard ELISA kits according to the
manufacture’s instruction (eBioscience).
Statistical analysis
All values are expressed as mean 6 SD. Treatment related
differences were evaluated by ANOVA. The paired-individual
means were compared by t-test. P values of less than 0.05 were
considered statistically significant.
Results
Reduction of hepatic Tregs in NKT deficient mice
There are several reports of cross talk between NKT cells and
Tregs [30,31,32]. However, there is little evidence of whether
NKT cell deficiency leads to a reduction in Treg number or
function. In this study, we first examined the basal number of
Tregs in NKT cell deficient (CD1dko) mice. There was a
significant decrease of Tregs in the livers of CD1dko mice (Fig. 1
A and B). However, the reduction in Tregs was limited to the liver.
The number of Tregs in the spleen of CD1dko mice was similar to
those of wt mice (Fig. 1A and B). Because liver has a high
percentage of IL-2 producing NKT cells, which is necessary for
Treg development [20], we next evaluated hepatic IL-2 expression
in CD1dko and wt mice. Intracellular cytokine staining showed a
slightly decrease in IL-2 expression among HMNC from CD1dko
mice, while IL-2 expression in the spleens of wt and CD1dko mice
was similar (Fig. 1C and D). There was a trend of reduction in IL-
2 transcription and translation level, as shown by qPCR and
ELISA (Fig. 1E and F), although they didn’t reach statistical
significance. Hepatic Treg number returned to normal levels after
CD1dko mice received exogenous IL-2 (Fig. 1G). Taken together,
it is likely that local IL-2 secretion controlled by NKT cells
regulates the accumulation of Tregs in the liver and leads to
decreased hepatic Tregs in CD1dko mice.
Tregs display CD1d dependent NKT cell suppression
A previous study has shown that human Tregs suppress NKT
cell proliferation and cytokine production [23]. To better
understand the mechanism by which Tregs regulate NKT cell
function, we performed lymphocyte suppression assays using
freshly isolated Tregs. CD4
+ CD25
+ Tregs were sorted from the
spleens of either wt or CD1dko mice. Given that Foxp3 represents
a single definitive Treg marker [8], we determined its expression
on isolated CD4
+ CD25
+ Tregs and found that the majority of
these cells in both groups were Foxp3
+ cells (Fig. S1A). Other
functional markers such as CTLA-4, CD62L and CD103 were
also similarly expressed on Tregs from either wt or CD1dko mice
(Fig 2A). Notably, Tregs from wt mice express CD1d, which was
absent on Tregs from CD1dko mice (Fig. S1B). Nevertheless both
groups displayed a similar ability to suppress conventional T cell
proliferation (Fig 2B). Next, we evaluated whether Tregs can also
suppress NKT proliferation. Purified wt NKT cells were cultured
with a-Galcer-loaded splenocytes in the presence or absence of
Tregs from either wt or CD1dko mice. Tregs from wt mice
demonstrated much stronger inhibitory capacity on NKT cell
proliferation than those from CD1dko mice (Fig 2C). Because wt
Tregs express CD1d (Fig. S1B), to rule out the possibility that
NKT cells maybe stimulated by wt Tregs in association of either
endogenous or exogenous ligands (a-Galcer) presented by CD1d
molecules, NKT cells were cultured with wt Tregs in the absence
of splenocytes. No NKT cell proliferation was observed (data not
shown). In addition, the a-Galcer-pulsed splenocytes were washed
extensively to remove the residual a-Galcer before being added to
the culture system. These results indicate that Tregs alone cannot
effectively stimulate NKT cells. Furthermore, when NKT cells
were activated by anti-CD3 mAbs, which do not require CD1d-
mediated ligand presentation, a similar inhibitory effect was
observed on NKT cells proliferation by wt Tregs but much less by
CD1dko Tregs (Fig. S2). Taken together, these results demonstrate
that Tregs inhibit activation-induced NKT cell proliferation in a
CD1d-dependent manner.
Upon stimulation NKT cells rapidly produce many cytokines,
including IFN-c and IL-4. Next, we evaluated whether Tregs
could also suppress activation-induced cytokine production by
NKT cells. NKT cells were co-incubated with a-Galcer loaded
APC in the presence of Tregs isolated from either wt or CD1dko
mice. Co-culture supernatants were harvested and cytokine
production was measured by standard cytokine ELISA. We found
that, in addition to their ability to inhibit NKT cell proliferation,
Figure 2. CD1d deficient Tregs have a reduced capacity to suppress NKT cells. Tregs (CD4
+ CD25
+) were isolated from the spleen of wt and
CD1dko mice. NKT cells (NK1.1
+, TCRb
+) and Teffs (CD4
+ CD25
-) were isolated from the liver and the spleen of wt mice, respectively. A) Representative
dot plots of isolated Tregs from each animal of one experiment. Mean (6SD) results were listed on the graph. Tregs from wt and CD1dko mice share
similar Treg surface markers. B) Tregs suppress Teff proliferation assay. Teffs (5610
4/well) were co-cultured with different amount of either wt or
CD1dko Tregs as labeled on the graph in present of APC (mitomycin C-treated wt splenocytes, 5610
4/well) and anti-CD3. Mean (6SD) results were
graphed. C) Tregs suppress NKT cell proliferation assay. NKT cells (5610
4/well) were co-cultured with different amount of either wt or CD1dko Tregs
as labeled on the graph in present of APC (a-Galcer-loaded and mitomycin C-treated wt splenocytes, 5610
4/well). The APCs were washed extensively
to remove excessive a-Galcer before added to the co-culture. Mean (6SD) results were graphed. *p,0.05 vs wt mice. E, F) Tregs suppress NKT cell
function assays. NKT cells were isolated and co-cultured with APCs and Tregs from wt and CD1dko mice, as described above. IFN-c (E) and IL-4 (F)
released to the culture media were determined by ELISA. Mean (6SD) results were graphed. (B–F, n=3/exp, and the experiments were repeated
three times). *p,0.05 vs wt mice.
doi:10.1371/journal.pone.0027038.g002
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PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27038Figure 3. CD1d dependent conjugation of Tregs and NKT cells. Tregs were isolated and co-cultured with either NKT cell hybridomas (A and
B) or purified primary NKT cells (C-E). A) Representative dot plots of cells after co-culture for 60 minutes. CD25 represents Treg marker and CD1d
tetramer represents NKT cell marker. CD25
+ CD1d tetramer
+ cells indicated conjugation of Tregs and NKT cells. B) Time course of Treg and NKT cell
conjugation after co-culture. C, D) NKT cells and Tregs were labeled with green and red dye, respectively, and co-cultured while their co-localization
was measured with confocal microscopy. C) Representative cofocal images showed at the beginning and the end of culture. NKT cells only
conjugated with wt Tregs as indicated as yellow colored double labeling. D) Pearson’s correlation coefficients were used to determine the
conjugation. The coefficient of .0.5 indicated conjugation and ,0.5 indicated no conjugation. E) NKT cell proliferation assays similar to those
described in Fig. 2C except the Tregs were placed in transwells. NKT:Treg=1:1, (B – E, n=3/exp, and the experiments were repeated three times).
doi:10.1371/journal.pone.0027038.g003
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suppressing NKT cell function, compare to CD1d deficient Tregs
(Fig. 2D, E).
The suppression of Tregs by NKT cells requires CD1d
mediated cell to cell contact
CD1d molecules present ligands to NKT cells via conjugation
with an invariant T cell receptor. Our results indicated that the
suppressive function of Tregs on NKT cells was CD1d-dependent.
We co-incubated Va14
+ NKT hybridoma with Tregs from wt
mice and CD1dko mice to examine whether Tregs suppression of
NKT cells requires conjugation and cell to cell contact. After co-
culturing NKT hybridoma and Tregs, there was dual-expression
of both Treg and NKT markers, indicating their conjugation
(Fig. 3A, B). Importantly, we found that only Tregs from wt mice,
not CD1dko mice, conjugated with NKT hybridoma. Further-
more, conjugate formation was blocked by the addition of anti-
CD1d mAb (Fig. 3A, B). To further confirm the conjugation
between NKT cells and Tregs, we labeled purified primary NKT
cells and Tregs with green and red dye, respectively, and co-
cultured them while measuring their co-localization with confocal
microscopy (Fig. 3C). Using Pearson’s correlation coefficients as
described previously [26], we found that NKT cells conjugated
with wt Tregs (.0.5), but not with CD1d deficient Tregs (,0.5)
(Fig. 3D). In addition, we examined whether Treg mediated
suppression of NKT cell function was contact dependent. We
found that when Tregs were placed in transwells and cultured
above primary NKT cells, their ability to suppress NKT cells was
abolished (Fig. 3E). These data provide some indication that the
suppression by Tregs of NKT cells is both CD1d and cell-contact
dependent.
Tregs induce NKT cell apoptosis
It has previously been described that Treg based suppression
involved both inhibition of target cell proliferation and induction
of apoptosis of target cells [33]. Thus, we evaluated whether Tregs
also induce apoptosis in activated NKT cells. Primary NKT cells
were activated with a-Galcer loaded APC, and then co-cultured
with Tregs from either wt or CD1dko mice, as previously
described. We then used Annexin-V staining to evaluate the level
of NKT cell apoptosis by simultaneously incubating the cells with
7-AAD to assess cellular necrosis. Apoptotic NKT cells were
Figure 4. CD1d-mediated Treg-induced NKT cell apoptosis. NKT cells and Tregs were isolated and co-cultured as described in Figure legend
2. NKT cell apoptosis was measured by AnnexinV staining with concurrent incubation of 7-AAD to assess cell necrosis. A) Representative dot plot of
NKT cell (gated on CD1d-tetramer+ cells) apoptosis assay after co-cultured for 3 days. Apoptotic NKT cells are defined as Annexin-V
+/7-AAD
2. B)
Time-course analysis of NKT cell apoptosis induced by Tregs isolated from wt and CD1dko mice. (n=3 each group). C) Blocking of CD1d engagement
completely abrogated Treg-mediated NKT cell apoptosis. Purified Tregs from wt mice were first incubated with anti-CD1d mAb or isotype control
(10 g/ml, 1B1 clone, BD Biosciences) for 2 hours. After extensive washing, the Tregs were then co-cultured with NKT cells for 72 hours as described
above. Mean (6SD) of three experiments were graphed. (n=3/exp, and the experiments were repeated 3 times) *p,0.05 vs isotype control.
doi:10.1371/journal.pone.0027038.g004
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+/7-AAD
2. There was a significant increase
in the apoptosis of NKT cells induced by wt Tregs, whereas NKT
cells apoptosis was less frequent with Tregs from CD1dko mice
(Fig. 4A). Treg induced NKT cell apoptosis increased with time
(Fig. 4B) and could be blocked by anti-CD1d mAb (Fig. 4C).
These results further illustrated that Tregs may exert their
regulatory function on NKT cells via a CD1d dependent
mechanism.
Tregs inhibit NKT cell mediated hepatitis
NKT cells are known to mediate several forms of hepatitis
[34,35]. To evaluate whether the Tregs-induced suppression of
NKT cells has any biological relevance, wt mice were injected with
a-Galcer to elicit hepatitis, then splenic Tregs from wt or CD1dko
mice were adoptively transferred into these mice. Our previous
study shows homing of transferred Tregs in the liver using the
same method [36]. Wt Tregs, but not CD1dko Tregs, nor Teff,
significantly reduced hepatic inflammation induced by a-Galcer as
reflected by liver histology (Fig. 5A) and serum ALT levels
(Fig. 5B). These studies indicate that Tregs play an important
biological role in the regulation of NKT cell activation and NKT
cell mediated inflammation. In addition, these data demonstrate
that Treg mediated suppression of NKT cells is CD1d dependent
in vivo.
Discussion
Tregs and NKT cells are two distinct lymphocyte subsets. NKT
cells are enriched in the liver where they are the major component
of the innate immune defense. They recognize glycolipid antigens
presented by CD1d and respond to infections or inflammation
prior to the conventional adaptive immune responses. Hepatic
NKT cells include groups of functionally distinct subsets that can
both promote and suppress immune responses, and have been
implicated in the pathogenesis of a wide variety of autoimmune
and inflammatory diseases [37,38]. The regulatory function of
NKT cells is thought to be due to their ability to produce large
amounts of cytokines, particularly IL-4, IL-10 and IL-13 [39].
Here we show that NKT cells are likely to also promote the Treg
population in the liver, possible through IL-2, because NKT cell
deficient CD1dko mice have reduced IL-2 level and less Tregs in
the liver (Fig. 1). This provides another mechanism by which NKT
cells can regulate the immune response.
As a part of the adaptive immune response, Tregs recognize
antigens bound to MHC class-II molecules and mediate tolerance
through contact-dependent suppression of effector-cell prolifera-
tion [40]. Dysfunction of Tregs has been linked to autoimmune
hepatititis [41]. Cross-talk between NKT cells and Tregs has also
been described [19]. In fact, hepatic NKT cell number appears to
be increased in association with decreased hepatic Treg number in
some autoimmune liver diseases [10,42]. These observations
suggest that the dysregulation of NKT cell and Treg interactions
may contribute to the pathogenesis of autoimmune liver disease.
However, the mechanism of NKT cell and Treg cross regulation
has not been well characterized.
In this manuscript, we use both an in vivo animal model and an
in vitro cell culture system to study immune regulation and CD1d-
dependent cross-talk between NKT cells and Tregs in the liver.
We show that NKT cells induce or recruit Tregs to the liver,
because NKT cell deficiency (CD1dko mice) results in a reduction
in the population of hepatic Tregs. The decrease in Tregs in the
liver of NKT cell deficient mice are likely due to decreased hepatic
IL-2 and IL-4, major cytokines secreted by NKT cells. We also
demonstrated that Tregs express high levels of CD1d molecules on
their surface. Furthermore, we found that Tregs effectively
inhibited NKT cell proliferation through the induction of
apoptosis. This inhibitory effect was CD1d dependent, since
CD1dko Tregs have normal inhibitory activities on classical
effector T cells, while their inhibitory activities on NKT cells were
diminished and this effect could be blocked with CD1d-specific
mAbs. The inhibitory effect was also cell-cell contact dependent.
These observations provide insights to the pathogenesis of many
autoimmune related liver diseases. From a clinical point of view,
Figure 5. Tregs inhibit NKT cell mediated hepatitis. Tregs (CD4
+ CD25
+) and Teff (CD4
+CD25
2) were isolated from the spleen of either wt or
CD1dko C57BL6 mice and adoptively transferred (1.5610
6 Tregs for each recipient mouse) into wild-type C57BL6 mice. 24 hour after adoptive
transfer, the recipient mice were injected with a-Galcer to induce hepatits. Liver tissue and blood were collected 3 days later. A) Representative H&E
stain of liver histology. B) Mean (6SD) serum ALT levels of four experiments, *p,0.01 vs other groups treated with a-Galcer.
doi:10.1371/journal.pone.0027038.g005
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activation and proliferation as part of the innate immune response.
Once activated, NKT cells secrete IL-2 and IL-4 to recruit or
induce Tregs to the liver as part of the adaptive immune response,
which, in turn, inhibits NKT cell proliferation and promote NKT
cell apoptosis to limit the NKT cell mediated inflammatory
response. This feedback mechanism prevents excessive inflamma-
tion. Any dysregulation of NKT cell and Treg cross-talk may
contribute to the pathogenesis of immune mediated liver diseases.
Our animal model, with NKT cell-mediated hepatitis, indicates
the importance of this cross-talk and regulation. However, the
molecular mechanism of Treg and NKT cell interaction is still
unclear. The receptor complex and intracellular signaling pathway
that mediate Treg and NKT cell interaction are still under
investigation.
It should be noted that, although the suppressive ability of wt
Tregs was much higher than that of CD1dko Tregs, the latter still
exerted some inhibitory effects on NKT cells (Fig 3). Multiple
mechanisms behind Tregs suppressive function have been
proposed, including contact-dependent suppression of effector-cell
proliferation involving IL-10 and transforming growth factor
(TGF)– b [40], and modulation of dendritic cell maturation and
function [43]. Therefore, it is possible that other suppressive
mechanisms in addition to the CD1d mediated-cell to cell contact
also play role in the cross-talk between Tregs and NKT cells.
These other mechanisms are currently under investigation.
In summary, we show that NKT cells and Tregs, two major
regulatory sub-populations of lymphocytes that belong to the
innate and adaptive immune system, interact with each other in
the liver to generate an effective, but tightly-regulated immune
response. This provides a novel concept of hepatic immune
regulation and the possible pathogenesis of immune mediated liver
diseases.
Supporting Information
Figure S1 A) Representative histogram of Foxp3 intracellular
staining that showed the majority of isolated CD4
+ CD25
+ cells
are Tregs with similar distribution between wt and CD1dko mice.
B) Representative histogram of CD1d staining on Tregs from wt
and CD1dko mice. Tregs from wt mice express CD1d, which was
absent on Tregs from CD1dko mice.
(TIF)
Figure S2 NKT cells were isolated from the liver of wt mice.
Tregs (5610
4/well) were purified from the spleen of either wt or
CD1dko mice, and co-cultured with NKT cells (5610
4/well) in
the present of anti-CD3 mAb and mitomycin C treated
splenocytes (5610
4/well). NKT cell proliferation was determined
by incorporation of [
3H] thymidine. Mean (6SD) results of
triplicates experiments were graphed.
ap,0.01 vs no-Treg group,
bp,0.01 vs CD1dko-Treg group.
(TIF)
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